Stockscreener 앱 받기
112.97
0.36%
0.41
시간 외 거래:
112.90
-0.07
-0.06%
Gilead Sciences Inc 주식(GILD)의 최신 뉴스
What earnings revisions data tells us about Gilead Sciences Inc.2025 Institutional Moves & High Yield Stock Recommendations - Newser
Gilead Sciences Inc. Recovery Likely Here’s What Data Shows getLinesFromResByArray error: size == 0 - thegnnews.com
Gilead Sciences’ SWOT analysis: HIV giant faces challenges, oncology promise - Investing.com
Is Gilead Sciences Inc. currently under institutional pressureTrade Entry Summary & Target Return Focused Picks - خودرو بانک
Stock Analysis | Gilead Sciences OutlookBullish Technicals and Mixed Analyst Signals - AInvest
Will Gilead Sciences Inc. stock go up soonQuarterly Portfolio Review & Free High Return Stock Watch Alerts - Newser
Technical analysis overview for Gilead Sciences Inc. stockQuarterly Profit Review & AI Based Buy and Sell Signals - Newser
Visual trend scoring systems applied to Gilead Sciences Inc.Fed Meeting & Fast Gain Stock Trading Tips - Newser
Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission - MSN
Forecasting Gilead Sciences Inc. price range with options dataJuly 2025 Breakouts & Smart Money Movement Tracker - Newser
Price action breakdown for Gilead Sciences Inc.Earnings Overview Summary & Safe Entry Trade Signal Reports - Newser
Will Gilead Sciences Inc. bounce back from current supportJuly 2025 Selloffs & Accurate Technical Buy Alerts - Newser
Paving the Way for the Future Pipeline: Gilead Builds New State-of-the-Art Research Center - Gilead Sciences
Gilead Climbs 0.36% on Strong-Buy Upgrade and Institutional Buys Despite 174th-Ranked 0.52B Volume - AInvest
Gilead Sciences' Insider Selling: Liquidity Management or Early Warning Signal? - AInvest
Statistical indicators supporting Gilead Sciences Inc.’s strength2025 Key Lessons & Low Risk High Win Rate Stock Picks - Newser
Applying Wyckoff theory to Gilead Sciences Inc. stock2025 Geopolitical Influence & Advanced Technical Analysis Signals - Newser
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - MSN
Does Gilead Sciences Inc. show high probability of rebound2025 Technical Patterns & Risk Controlled Daily Trade Plans - Newser
How hedge fund analytics apply to Gilead Sciences Inc. stock2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Gilead Sciences Advances Ulcerative Colitis Treatment with GS-1427 Study - TipRanks
Gilead and Arcus Biosciences Complete Promising Cancer Study - TipRanks
HER2-Negative Metastatic Breast Cancer Market Positioned for Accelerated Development Through 2032, DelveInsight Finds | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene, Eisai - The Globe and Mail
Gilead details discovery of oral integrin inhibitor GS-1427 - BioWorld MedTech
Using portfolio simulators with Gilead Sciences Inc. includedMarket Sentiment Report & Weekly Top Performers Watchlists - Newser
Will Gilead Sciences Inc. rebound enough to break even2025 Market Trends & Growth Focused Stock Pick Reports - Newser
Gilead Shares Plunge 0.72% as Trading Volume Tanks to 146th in $530M Turnover - AInvest
Gilead granted EU nod for twice-yearly HIV PrEP therapy - MSN
Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why - MSN
US judge recuses herself from black-market drug case over Gilead stock purchases - Reuters
Those Who Invested in Gilead Sciences (NASDAQ:GILD) Three Years Ago Are up 105% - 富途牛牛
0.65%
0.92%
자본화:
|
볼륨(24시간):